Potential application areas: Alzheimer’s disease, Parkinson’s disease, Huntington’s disease, Schizophrenia, Depression, Multiple Sclerosis, Spinal Muscular Atrophy (SMA), etc.
The identification and characterization of novel biomarkers for neurodegenerative, neuropsychiatric, and neuromuscular diseases promises to make significant contributions towards early detection and the development of therapeutic intervention.
Below is a list of blood-based protein biomarkers in our menu that have demonstrated links to neurodegenerative, neuropsychiatric, and neuromuscular diseases in the scientific literature. The products listed here may also contain biomarkers useful in neuroscience research.
Click or mouse over biomarkers for more information